Opinion/decision on a Paediatric investigation plan (PIP): Qdenga, Dengue tetravalent vaccine (live, attenuated), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: EMA/PE/0000224202

EMA/PE/0000221803

Product Management Service (PMS) roadmap

Good pharmacogenomic practice - Scientific guideline

Call for user acceptance testers for the read functionality in the Public Product Management Service (PMS) Application Programming Interface (API)

Remsima

Human medicines European public assessment report (EPAR): Ravicti, glycerol phenylbutyrate, Date of authorisation: 26/11/2015, Revision: 19, Status: Authorised

Agenda - HMA/EMA Annual Data Forum 2025

Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Zomarist, vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 27, Status: Authorised